nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—Exemestane—breast cancer	0.358	1	CrCtD
Methylprednisolone—CYP3A4—breast cancer	0.0658	0.546	CbGaD
Methylprednisolone—ABCB1—breast cancer	0.0548	0.454	CbGaD
Methylprednisolone—NR3C1—Fluoxymesterone—breast cancer	0.0547	0.281	CbGbCtD
Methylprednisolone—Testolactone—Exemestane—breast cancer	0.0159	0.0706	CrCrCtD
Methylprednisolone—Prednisone—Exemestane—breast cancer	0.0143	0.0633	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Exemestane—breast cancer	0.0132	0.0587	CrCrCtD
Methylprednisolone—Loteprednol—Exemestane—breast cancer	0.0132	0.0587	CrCrCtD
Methylprednisolone—Medroxyprogesterone Acetate—Fluoxymesterone—breast cancer	0.013	0.0577	CrCrCtD
Methylprednisolone—ABCB1—Toremifene—breast cancer	0.0127	0.0654	CbGbCtD
Methylprednisolone—Prednisolone—Exemestane—breast cancer	0.0121	0.0537	CrCrCtD
Methylprednisolone—Hydrocortamate—Fluoxymesterone—breast cancer	0.0117	0.0521	CrCrCtD
Methylprednisolone—Cortisone acetate—Fluoxymesterone—breast cancer	0.0114	0.0505	CrCrCtD
Methylprednisolone—Testolactone—Fluoxymesterone—breast cancer	0.011	0.049	CrCrCtD
Methylprednisolone—CYP3A4—Exemestane—breast cancer	0.011	0.0565	CbGbCtD
Methylprednisolone—Fludrocortisone—Fluoxymesterone—breast cancer	0.00989	0.0438	CrCrCtD
Methylprednisolone—Clobetasol propionate—Fluoxymesterone—breast cancer	0.00989	0.0438	CrCrCtD
Methylprednisolone—Desoximetasone—Fluoxymesterone—breast cancer	0.0094	0.0417	CrCrCtD
Methylprednisolone—CYP3A4—Letrozole—breast cancer	0.00936	0.048	CbGbCtD
Methylprednisolone—ABCB1—Lapatinib—breast cancer	0.00929	0.0477	CbGbCtD
Methylprednisolone—Triamcinolone—Fluoxymesterone—breast cancer	0.00918	0.0407	CrCrCtD
Methylprednisolone—Mometasone—Fluoxymesterone—breast cancer	0.00918	0.0407	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.00918	0.0407	CrCrCtD
Methylprednisolone—Loteprednol—Fluoxymesterone—breast cancer	0.00918	0.0407	CrCrCtD
Methylprednisolone—Fluorometholone—Fluoxymesterone—breast cancer	0.00918	0.0407	CrCrCtD
Methylprednisolone—Betamethasone—Fluoxymesterone—breast cancer	0.00897	0.0398	CrCrCtD
Methylprednisolone—Dexamethasone—Fluoxymesterone—breast cancer	0.00897	0.0398	CrCrCtD
Methylprednisolone—Prednisolone—Fluoxymesterone—breast cancer	0.0084	0.0373	CrCrCtD
Methylprednisolone—CYP3A4—Anastrozole—breast cancer	0.00834	0.0428	CbGbCtD
Methylprednisolone—Hydrocortisone—Fluoxymesterone—breast cancer	0.00806	0.0358	CrCrCtD
Methylprednisolone—CYP3A4—Toremifene—breast cancer	0.00763	0.0392	CbGbCtD
Methylprednisolone—CYP3A4—Fulvestrant—breast cancer	0.00709	0.0364	CbGbCtD
Methylprednisolone—CYP3A4—Thiotepa—breast cancer	0.00632	0.0325	CbGbCtD
Methylprednisolone—CYP3A4—Ixabepilone—breast cancer	0.00578	0.0297	CbGbCtD
Methylprednisolone—CYP3A4—Lapatinib—breast cancer	0.00556	0.0286	CbGbCtD
Methylprednisolone—ABCB1—Vinorelbine—breast cancer	0.00515	0.0265	CbGbCtD
Methylprednisolone—ABCB1—Tamoxifen—breast cancer	0.00465	0.0239	CbGbCtD
Methylprednisolone—ABCB1—Mitoxantrone—breast cancer	0.00454	0.0233	CbGbCtD
Methylprednisolone—CYP3A4—Raloxifene—breast cancer	0.00422	0.0217	CbGbCtD
Methylprednisolone—ABCB1—Gemcitabine—breast cancer	0.00401	0.0206	CbGbCtD
Methylprednisolone—ABCB1—Paclitaxel—breast cancer	0.00362	0.0186	CbGbCtD
Methylprednisolone—ABCB1—Irinotecan—breast cancer	0.00357	0.0183	CbGbCtD
Methylprednisolone—ABCB1—Vinblastine—breast cancer	0.00317	0.0163	CbGbCtD
Methylprednisolone—CYP3A4—Vinorelbine—breast cancer	0.00309	0.0158	CbGbCtD
Methylprednisolone—CYP3A4—Tamoxifen—breast cancer	0.00279	0.0143	CbGbCtD
Methylprednisolone—CYP3A4—Mitoxantrone—breast cancer	0.00272	0.014	CbGbCtD
Methylprednisolone—ABCB1—Docetaxel—breast cancer	0.00262	0.0134	CbGbCtD
Methylprednisolone—CYP3A4—Paclitaxel—breast cancer	0.00217	0.0111	CbGbCtD
Methylprednisolone—CYP3A4—Irinotecan—breast cancer	0.00214	0.011	CbGbCtD
Methylprednisolone—ABCB1—Doxorubicin—breast cancer	0.00195	0.01	CbGbCtD
Methylprednisolone—CYP3A4—Vinblastine—breast cancer	0.0019	0.00977	CbGbCtD
Methylprednisolone—ABCB1—Methotrexate—breast cancer	0.00189	0.0097	CbGbCtD
Methylprednisolone—CYP3A4—Docetaxel—breast cancer	0.00157	0.00805	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—breast cancer	0.00117	0.006	CbGbCtD
Methylprednisolone—Fluocinolone Acetonide—PLA2G4A—breast cancer	0.000119	0.0735	CrCbGaD
Methylprednisolone—Exemestane—CYP19A1—breast cancer	9.02e-05	0.0558	CrCbGaD
Methylprednisolone—Testolactone—CYP19A1—breast cancer	8.6e-05	0.0532	CrCbGaD
Methylprednisolone—Fluticasone Propionate—PLA2G4A—breast cancer	8.13e-05	0.0503	CrCbGaD
Methylprednisolone—Fludrocortisone—AR—breast cancer	6.27e-05	0.0388	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—PGR—breast cancer	5.42e-05	0.0335	CrCbGaD
Methylprednisolone—Fluticasone Propionate—PGR—breast cancer	5.37e-05	0.0332	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—SHBG—breast cancer	5.07e-05	0.0313	CrCbGaD
Methylprednisolone—Betamethasone—PGR—breast cancer	4.92e-05	0.0305	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—AR—breast cancer	4.44e-05	0.0275	CrCbGaD
Methylprednisolone—Exemestane—CYP3A4—breast cancer	4.24e-05	0.0262	CrCbGaD
Methylprednisolone—Triamcinolone—BCHE—breast cancer	4.11e-05	0.0255	CrCbGaD
Methylprednisolone—Clobetasol propionate—CYP1A1—breast cancer	3.86e-05	0.0239	CrCbGaD
Methylprednisolone—Dexamethasone—CYP17A1—breast cancer	3.86e-05	0.0239	CrCbGaD
Methylprednisolone—Hydrocortisone—SHBG—breast cancer	3.59e-05	0.0222	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—ESR1—breast cancer	3.42e-05	0.0212	CrCbGaD
Methylprednisolone—Betamethasone—CYP19A1—breast cancer	3.38e-05	0.0209	CrCbGaD
Methylprednisolone—Hydrocortamate—CYP3A4—breast cancer	3.16e-05	0.0195	CrCbGaD
Methylprednisolone—Dexamethasone—NOS2—breast cancer	3.15e-05	0.0195	CrCbGaD
Methylprednisolone—Cortisone acetate—CYP3A4—breast cancer	3.11e-05	0.0192	CrCbGaD
Methylprednisolone—Budesonide—CYP3A4—breast cancer	2.94e-05	0.0182	CrCbGaD
Methylprednisolone—Dexamethasone—PGR—breast cancer	2.86e-05	0.0177	CrCbGaD
Methylprednisolone—Ciclesonide—CYP2D6—breast cancer	2.79e-05	0.0173	CrCbGaD
Methylprednisolone—Dexamethasone—CYP1B1—breast cancer	2.68e-05	0.0166	CrCbGaD
Methylprednisolone—Alclometasone—CYP3A4—breast cancer	2.53e-05	0.0157	CrCbGaD
Methylprednisolone—Hydrocortisone—ABCG2—breast cancer	2.48e-05	0.0153	CrCbGaD
Methylprednisolone—Flunisolide—CYP3A4—breast cancer	2.46e-05	0.0152	CrCbGaD
Methylprednisolone—Paramethasone—CYP3A4—breast cancer	2.43e-05	0.0151	CrCbGaD
Methylprednisolone—Ciclesonide—CYP3A4—breast cancer	2.39e-05	0.0148	CrCbGaD
Methylprednisolone—Fluorometholone—CYP3A4—breast cancer	2.37e-05	0.0147	CrCbGaD
Methylprednisolone—Dexamethasone—CYP19A1—breast cancer	1.96e-05	0.0122	CrCbGaD
Methylprednisolone—Triamcinolone—CYP3A4—breast cancer	1.94e-05	0.012	CrCbGaD
Methylprednisolone—Triamcinolone—PTGS2—breast cancer	1.9e-05	0.0117	CrCbGaD
Methylprednisolone—Dexamethasone—ABCG2—breast cancer	1.84e-05	0.0114	CrCbGaD
Methylprednisolone—Prednisone—CYP3A4—breast cancer	1.76e-05	0.0109	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—CYP3A4—breast cancer	1.75e-05	0.0108	CrCbGaD
Methylprednisolone—Fluticasone Propionate—CYP3A4—breast cancer	1.73e-05	0.0107	CrCbGaD
Methylprednisolone—Prednisolone—CYP3A4—breast cancer	1.62e-05	0.01	CrCbGaD
Methylprednisolone—Betamethasone—CYP3A4—breast cancer	1.59e-05	0.00981	CrCbGaD
Methylprednisolone—Betamethasone—PTGS2—breast cancer	1.55e-05	0.00961	CrCbGaD
Methylprednisolone—Nausea—Thiotepa—breast cancer	1.54e-05	0.000205	CcSEcCtD
Methylprednisolone—Infection—Docetaxel—breast cancer	1.53e-05	0.000205	CcSEcCtD
Methylprednisolone—Prednisone—ALB—breast cancer	1.53e-05	0.00948	CrCbGaD
Methylprednisolone—Diarrhoea—Mitoxantrone—breast cancer	1.53e-05	0.000204	CcSEcCtD
Methylprednisolone—Diarrhoea—Irinotecan—breast cancer	1.53e-05	0.000204	CcSEcCtD
Methylprednisolone—Shock—Docetaxel—breast cancer	1.52e-05	0.000203	CcSEcCtD
Methylprednisolone—Nervous system disorder—Docetaxel—breast cancer	1.51e-05	0.000202	CcSEcCtD
Methylprednisolone—Pruritus—Fluorouracil—breast cancer	1.51e-05	0.000202	CcSEcCtD
Methylprednisolone—Infestation—Doxorubicin—breast cancer	1.51e-05	0.000201	CcSEcCtD
Methylprednisolone—Infestation NOS—Doxorubicin—breast cancer	1.51e-05	0.000201	CcSEcCtD
Methylprednisolone—Visual impairment—Methotrexate—breast cancer	1.51e-05	0.000201	CcSEcCtD
Methylprednisolone—Confusional state—Capecitabine—breast cancer	1.51e-05	0.000201	CcSEcCtD
Methylprednisolone—Tachycardia—Docetaxel—breast cancer	1.51e-05	0.000201	CcSEcCtD
Methylprednisolone—Feeling abnormal—Paclitaxel—breast cancer	1.5e-05	0.0002	CcSEcCtD
Methylprednisolone—Skin disorder—Docetaxel—breast cancer	1.5e-05	0.0002	CcSEcCtD
Methylprednisolone—Bradycardia—Epirubicin—breast cancer	1.49e-05	0.000199	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Paclitaxel—breast cancer	1.49e-05	0.000199	CcSEcCtD
Methylprednisolone—Diarrhoea—Gemcitabine—breast cancer	1.49e-05	0.000199	CcSEcCtD
Methylprednisolone—Infection—Capecitabine—breast cancer	1.49e-05	0.000198	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Doxorubicin—breast cancer	1.48e-05	0.000198	CcSEcCtD
Methylprednisolone—Dizziness—Irinotecan—breast cancer	1.48e-05	0.000197	CcSEcCtD
Methylprednisolone—Haemoglobin—Epirubicin—breast cancer	1.47e-05	0.000196	CcSEcCtD
Methylprednisolone—Shock—Capecitabine—breast cancer	1.47e-05	0.000196	CcSEcCtD
Methylprednisolone—Rhinitis—Epirubicin—breast cancer	1.47e-05	0.000196	CcSEcCtD
Methylprednisolone—Nervous system disorder—Capecitabine—breast cancer	1.47e-05	0.000196	CcSEcCtD
Methylprednisolone—Haemorrhage—Epirubicin—breast cancer	1.47e-05	0.000195	CcSEcCtD
Methylprednisolone—Eye disorder—Methotrexate—breast cancer	1.46e-05	0.000195	CcSEcCtD
Methylprednisolone—Diarrhoea—Fluorouracil—breast cancer	1.46e-05	0.000195	CcSEcCtD
Methylprednisolone—Prednisone—ABCB1—breast cancer	1.46e-05	0.00904	CrCbGaD
Methylprednisolone—Tachycardia—Capecitabine—breast cancer	1.46e-05	0.000195	CcSEcCtD
Methylprednisolone—Cardiac disorder—Methotrexate—breast cancer	1.45e-05	0.000194	CcSEcCtD
Methylprednisolone—Skin disorder—Capecitabine—breast cancer	1.45e-05	0.000194	CcSEcCtD
Methylprednisolone—Sweating—Doxorubicin—breast cancer	1.45e-05	0.000193	CcSEcCtD
Methylprednisolone—Urticaria—Paclitaxel—breast cancer	1.45e-05	0.000193	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Capecitabine—breast cancer	1.45e-05	0.000193	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP1A1—breast cancer	1.44e-05	0.00894	CrCbGaD
Methylprednisolone—Hypotension—Docetaxel—breast cancer	1.44e-05	0.000192	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Epirubicin—breast cancer	1.44e-05	0.000192	CcSEcCtD
Methylprednisolone—Abdominal pain—Paclitaxel—breast cancer	1.44e-05	0.000192	CcSEcCtD
Methylprednisolone—Angiopathy—Methotrexate—breast cancer	1.42e-05	0.00019	CcSEcCtD
Methylprednisolone—Vomiting—Mitoxantrone—breast cancer	1.42e-05	0.000189	CcSEcCtD
Methylprednisolone—Vomiting—Irinotecan—breast cancer	1.42e-05	0.000189	CcSEcCtD
Methylprednisolone—Immune system disorder—Methotrexate—breast cancer	1.42e-05	0.000189	CcSEcCtD
Methylprednisolone—Dizziness—Fluorouracil—breast cancer	1.42e-05	0.000189	CcSEcCtD
Methylprednisolone—Visual impairment—Epirubicin—breast cancer	1.41e-05	0.000188	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Methotrexate—breast cancer	1.41e-05	0.000188	CcSEcCtD
Methylprednisolone—Rash—Mitoxantrone—breast cancer	1.41e-05	0.000188	CcSEcCtD
Methylprednisolone—Rash—Irinotecan—breast cancer	1.41e-05	0.000188	CcSEcCtD
Methylprednisolone—Dermatitis—Mitoxantrone—breast cancer	1.41e-05	0.000188	CcSEcCtD
Methylprednisolone—Dermatitis—Irinotecan—breast cancer	1.41e-05	0.000188	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Docetaxel—breast cancer	1.41e-05	0.000188	CcSEcCtD
Methylprednisolone—Headache—Mitoxantrone—breast cancer	1.4e-05	0.000187	CcSEcCtD
Methylprednisolone—Headache—Irinotecan—breast cancer	1.4e-05	0.000187	CcSEcCtD
Methylprednisolone—Hypotension—Capecitabine—breast cancer	1.4e-05	0.000186	CcSEcCtD
Methylprednisolone—Insomnia—Docetaxel—breast cancer	1.4e-05	0.000186	CcSEcCtD
Methylprednisolone—Paraesthesia—Docetaxel—breast cancer	1.39e-05	0.000185	CcSEcCtD
Methylprednisolone—Vomiting—Gemcitabine—breast cancer	1.38e-05	0.000184	CcSEcCtD
Methylprednisolone—Bradycardia—Doxorubicin—breast cancer	1.38e-05	0.000184	CcSEcCtD
Methylprednisolone—Mental disorder—Methotrexate—breast cancer	1.37e-05	0.000183	CcSEcCtD
Methylprednisolone—Rash—Gemcitabine—breast cancer	1.37e-05	0.000183	CcSEcCtD
Methylprednisolone—Dermatitis—Gemcitabine—breast cancer	1.37e-05	0.000183	CcSEcCtD
Methylprednisolone—Eye disorder—Epirubicin—breast cancer	1.37e-05	0.000183	CcSEcCtD
Methylprednisolone—Erythema—Methotrexate—breast cancer	1.36e-05	0.000182	CcSEcCtD
Methylprednisolone—Malnutrition—Methotrexate—breast cancer	1.36e-05	0.000182	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—breast cancer	1.36e-05	0.000182	CcSEcCtD
Methylprednisolone—Headache—Gemcitabine—breast cancer	1.36e-05	0.000182	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Capecitabine—breast cancer	1.36e-05	0.000182	CcSEcCtD
Methylprednisolone—Cardiac disorder—Epirubicin—breast cancer	1.36e-05	0.000181	CcSEcCtD
Methylprednisolone—Vomiting—Fluorouracil—breast cancer	1.36e-05	0.000181	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—breast cancer	1.36e-05	0.000181	CcSEcCtD
Methylprednisolone—Dyspepsia—Docetaxel—breast cancer	1.36e-05	0.000181	CcSEcCtD
Methylprednisolone—Haemorrhage—Doxorubicin—breast cancer	1.36e-05	0.000181	CcSEcCtD
Methylprednisolone—Insomnia—Capecitabine—breast cancer	1.35e-05	0.00018	CcSEcCtD
Methylprednisolone—Rash—Fluorouracil—breast cancer	1.35e-05	0.00018	CcSEcCtD
Methylprednisolone—Dermatitis—Fluorouracil—breast cancer	1.35e-05	0.00018	CcSEcCtD
Methylprednisolone—Prednisolone—ABCB1—breast cancer	1.35e-05	0.00834	CrCbGaD
Methylprednisolone—Paraesthesia—Capecitabine—breast cancer	1.34e-05	0.000179	CcSEcCtD
Methylprednisolone—Hypersensitivity—Paclitaxel—breast cancer	1.34e-05	0.000179	CcSEcCtD
Methylprednisolone—Headache—Fluorouracil—breast cancer	1.34e-05	0.000179	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Doxorubicin—breast cancer	1.33e-05	0.000178	CcSEcCtD
Methylprednisolone—Fatigue—Docetaxel—breast cancer	1.33e-05	0.000178	CcSEcCtD
Methylprednisolone—Angiopathy—Epirubicin—breast cancer	1.33e-05	0.000177	CcSEcCtD
Methylprednisolone—Nausea—Irinotecan—breast cancer	1.33e-05	0.000177	CcSEcCtD
Methylprednisolone—Nausea—Mitoxantrone—breast cancer	1.33e-05	0.000177	CcSEcCtD
Methylprednisolone—Immune system disorder—Epirubicin—breast cancer	1.32e-05	0.000177	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Epirubicin—breast cancer	1.32e-05	0.000176	CcSEcCtD
Methylprednisolone—Betamethasone—ABCB1—breast cancer	1.32e-05	0.00817	CrCbGaD
Methylprednisolone—Dyspepsia—Capecitabine—breast cancer	1.32e-05	0.000175	CcSEcCtD
Methylprednisolone—Arrhythmia—Epirubicin—breast cancer	1.31e-05	0.000175	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—breast cancer	1.31e-05	0.000174	CcSEcCtD
Methylprednisolone—Asthenia—Paclitaxel—breast cancer	1.31e-05	0.000174	CcSEcCtD
Methylprednisolone—Nausea—Gemcitabine—breast cancer	1.29e-05	0.000172	CcSEcCtD
Methylprednisolone—Fatigue—Capecitabine—breast cancer	1.29e-05	0.000172	CcSEcCtD
Methylprednisolone—Pruritus—Paclitaxel—breast cancer	1.29e-05	0.000172	CcSEcCtD
Methylprednisolone—Mental disorder—Epirubicin—breast cancer	1.28e-05	0.000171	CcSEcCtD
Methylprednisolone—Malnutrition—Epirubicin—breast cancer	1.28e-05	0.00017	CcSEcCtD
Methylprednisolone—Erythema—Epirubicin—breast cancer	1.28e-05	0.00017	CcSEcCtD
Methylprednisolone—Feeling abnormal—Docetaxel—breast cancer	1.27e-05	0.00017	CcSEcCtD
Methylprednisolone—Nausea—Fluorouracil—breast cancer	1.27e-05	0.000169	CcSEcCtD
Methylprednisolone—Eye disorder—Doxorubicin—breast cancer	1.27e-05	0.000169	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Methotrexate—breast cancer	1.27e-05	0.000169	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Docetaxel—breast cancer	1.26e-05	0.000168	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—breast cancer	1.26e-05	0.000168	CcSEcCtD
Methylprednisolone—Diarrhoea—Paclitaxel—breast cancer	1.25e-05	0.000166	CcSEcCtD
Methylprednisolone—Hydrocortisone—CYP3A4—breast cancer	1.24e-05	0.00766	CrCbGaD
Methylprednisolone—Feeling abnormal—Capecitabine—breast cancer	1.23e-05	0.000164	CcSEcCtD
Methylprednisolone—Angiopathy—Doxorubicin—breast cancer	1.23e-05	0.000164	CcSEcCtD
Methylprednisolone—Malaise—Methotrexate—breast cancer	1.23e-05	0.000164	CcSEcCtD
Methylprednisolone—Immune system disorder—Doxorubicin—breast cancer	1.23e-05	0.000163	CcSEcCtD
Methylprednisolone—Vertigo—Methotrexate—breast cancer	1.23e-05	0.000163	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Capecitabine—breast cancer	1.22e-05	0.000163	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—breast cancer	1.22e-05	0.000163	CcSEcCtD
Methylprednisolone—Abdominal pain—Docetaxel—breast cancer	1.22e-05	0.000163	CcSEcCtD
Methylprednisolone—Arrhythmia—Doxorubicin—breast cancer	1.21e-05	0.000162	CcSEcCtD
Methylprednisolone—Dizziness—Paclitaxel—breast cancer	1.21e-05	0.000161	CcSEcCtD
Methylprednisolone—Mental disorder—Doxorubicin—breast cancer	1.19e-05	0.000158	CcSEcCtD
Methylprednisolone—Urticaria—Capecitabine—breast cancer	1.19e-05	0.000158	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Epirubicin—breast cancer	1.18e-05	0.000158	CcSEcCtD
Methylprednisolone—Abdominal pain—Capecitabine—breast cancer	1.18e-05	0.000158	CcSEcCtD
Methylprednisolone—Convulsion—Methotrexate—breast cancer	1.18e-05	0.000158	CcSEcCtD
Methylprednisolone—Erythema—Doxorubicin—breast cancer	1.18e-05	0.000157	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—breast cancer	1.18e-05	0.000157	CcSEcCtD
Methylprednisolone—Myalgia—Methotrexate—breast cancer	1.16e-05	0.000155	CcSEcCtD
Methylprednisolone—Arthralgia—Methotrexate—breast cancer	1.16e-05	0.000155	CcSEcCtD
Methylprednisolone—Vomiting—Paclitaxel—breast cancer	1.16e-05	0.000154	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.15e-05	0.000154	CcSEcCtD
Methylprednisolone—Malaise—Epirubicin—breast cancer	1.15e-05	0.000153	CcSEcCtD
Methylprednisolone—Rash—Paclitaxel—breast cancer	1.15e-05	0.000153	CcSEcCtD
Methylprednisolone—Dermatitis—Paclitaxel—breast cancer	1.15e-05	0.000153	CcSEcCtD
Methylprednisolone—Discomfort—Methotrexate—breast cancer	1.15e-05	0.000153	CcSEcCtD
Methylprednisolone—Vertigo—Epirubicin—breast cancer	1.15e-05	0.000153	CcSEcCtD
Methylprednisolone—Syncope—Epirubicin—breast cancer	1.14e-05	0.000153	CcSEcCtD
Methylprednisolone—Headache—Paclitaxel—breast cancer	1.14e-05	0.000152	CcSEcCtD
Methylprednisolone—Hypersensitivity—Docetaxel—breast cancer	1.14e-05	0.000152	CcSEcCtD
Methylprednisolone—Confusional state—Methotrexate—breast cancer	1.12e-05	0.00015	CcSEcCtD
Methylprednisolone—Loss of consciousness—Epirubicin—breast cancer	1.12e-05	0.00015	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Methotrexate—breast cancer	1.11e-05	0.000148	CcSEcCtD
Methylprednisolone—Asthenia—Docetaxel—breast cancer	1.11e-05	0.000148	CcSEcCtD
Methylprednisolone—Convulsion—Epirubicin—breast cancer	1.11e-05	0.000147	CcSEcCtD
Methylprednisolone—Infection—Methotrexate—breast cancer	1.11e-05	0.000147	CcSEcCtD
Methylprednisolone—Hypertension—Epirubicin—breast cancer	1.1e-05	0.000147	CcSEcCtD
Methylprednisolone—Hypersensitivity—Capecitabine—breast cancer	1.1e-05	0.000147	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Doxorubicin—breast cancer	1.1e-05	0.000146	CcSEcCtD
Methylprednisolone—Pruritus—Docetaxel—breast cancer	1.09e-05	0.000146	CcSEcCtD
Methylprednisolone—Nervous system disorder—Methotrexate—breast cancer	1.09e-05	0.000146	CcSEcCtD
Methylprednisolone—Myalgia—Epirubicin—breast cancer	1.09e-05	0.000145	CcSEcCtD
Methylprednisolone—Arthralgia—Epirubicin—breast cancer	1.09e-05	0.000145	CcSEcCtD
Methylprednisolone—Anxiety—Epirubicin—breast cancer	1.08e-05	0.000144	CcSEcCtD
Methylprednisolone—Nausea—Paclitaxel—breast cancer	1.08e-05	0.000144	CcSEcCtD
Methylprednisolone—Skin disorder—Methotrexate—breast cancer	1.08e-05	0.000144	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.08e-05	0.000144	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Methotrexate—breast cancer	1.08e-05	0.000143	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP2D6—breast cancer	1.08e-05	0.00665	CrCbGaD
Methylprednisolone—Discomfort—Epirubicin—breast cancer	1.07e-05	0.000143	CcSEcCtD
Methylprednisolone—Asthenia—Capecitabine—breast cancer	1.07e-05	0.000143	CcSEcCtD
Methylprednisolone—Malaise—Doxorubicin—breast cancer	1.07e-05	0.000142	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—breast cancer	1.06e-05	0.000141	CcSEcCtD
Methylprednisolone—Syncope—Doxorubicin—breast cancer	1.06e-05	0.000141	CcSEcCtD
Methylprednisolone—Pruritus—Capecitabine—breast cancer	1.06e-05	0.000141	CcSEcCtD
Methylprednisolone—Diarrhoea—Docetaxel—breast cancer	1.06e-05	0.000141	CcSEcCtD
Methylprednisolone—Confusional state—Epirubicin—breast cancer	1.05e-05	0.00014	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Epirubicin—breast cancer	1.04e-05	0.000139	CcSEcCtD
Methylprednisolone—Hypotension—Methotrexate—breast cancer	1.04e-05	0.000139	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—breast cancer	1.04e-05	0.000138	CcSEcCtD
Methylprednisolone—Infection—Epirubicin—breast cancer	1.04e-05	0.000138	CcSEcCtD
Methylprednisolone—Hydrocortisone—ABCB1—breast cancer	1.03e-05	0.00638	CrCbGaD
Methylprednisolone—Shock—Epirubicin—breast cancer	1.03e-05	0.000137	CcSEcCtD
Methylprednisolone—Convulsion—Doxorubicin—breast cancer	1.02e-05	0.000136	CcSEcCtD
Methylprednisolone—Diarrhoea—Capecitabine—breast cancer	1.02e-05	0.000136	CcSEcCtD
Methylprednisolone—Nervous system disorder—Epirubicin—breast cancer	1.02e-05	0.000136	CcSEcCtD
Methylprednisolone—Dizziness—Docetaxel—breast cancer	1.02e-05	0.000136	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—breast cancer	1.02e-05	0.000136	CcSEcCtD
Methylprednisolone—Tachycardia—Epirubicin—breast cancer	1.02e-05	0.000136	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Methotrexate—breast cancer	1.01e-05	0.000135	CcSEcCtD
Methylprednisolone—Skin disorder—Epirubicin—breast cancer	1.01e-05	0.000135	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Epirubicin—breast cancer	1.01e-05	0.000134	CcSEcCtD
Methylprednisolone—Insomnia—Methotrexate—breast cancer	1.01e-05	0.000134	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—breast cancer	1.01e-05	0.000134	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—breast cancer	1.01e-05	0.000134	CcSEcCtD
Methylprednisolone—Anxiety—Doxorubicin—breast cancer	1e-05	0.000134	CcSEcCtD
Methylprednisolone—Paraesthesia—Methotrexate—breast cancer	1e-05	0.000133	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	9.99e-06	0.000133	CcSEcCtD
Methylprednisolone—Discomfort—Doxorubicin—breast cancer	9.94e-06	0.000132	CcSEcCtD
Methylprednisolone—Dizziness—Capecitabine—breast cancer	9.89e-06	0.000132	CcSEcCtD
Methylprednisolone—Vomiting—Docetaxel—breast cancer	9.82e-06	0.000131	CcSEcCtD
Methylprednisolone—Dyspepsia—Methotrexate—breast cancer	9.8e-06	0.000131	CcSEcCtD
Methylprednisolone—Rash—Docetaxel—breast cancer	9.74e-06	0.00013	CcSEcCtD
Methylprednisolone—Hypotension—Epirubicin—breast cancer	9.74e-06	0.00013	CcSEcCtD
Methylprednisolone—Dermatitis—Docetaxel—breast cancer	9.73e-06	0.00013	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—breast cancer	9.72e-06	0.00013	CcSEcCtD
Methylprednisolone—Headache—Docetaxel—breast cancer	9.68e-06	0.000129	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Doxorubicin—breast cancer	9.64e-06	0.000129	CcSEcCtD
Methylprednisolone—Fatigue—Methotrexate—breast cancer	9.6e-06	0.000128	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—breast cancer	9.58e-06	0.000128	CcSEcCtD
Methylprednisolone—Vomiting—Capecitabine—breast cancer	9.51e-06	0.000127	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Epirubicin—breast cancer	9.49e-06	0.000127	CcSEcCtD
Methylprednisolone—Shock—Doxorubicin—breast cancer	9.48e-06	0.000126	CcSEcCtD
Methylprednisolone—Nervous system disorder—Doxorubicin—breast cancer	9.45e-06	0.000126	CcSEcCtD
Methylprednisolone—Rash—Capecitabine—breast cancer	9.43e-06	0.000126	CcSEcCtD
Methylprednisolone—Insomnia—Epirubicin—breast cancer	9.42e-06	0.000126	CcSEcCtD
Methylprednisolone—Dermatitis—Capecitabine—breast cancer	9.42e-06	0.000126	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—breast cancer	9.41e-06	0.000125	CcSEcCtD
Methylprednisolone—Headache—Capecitabine—breast cancer	9.37e-06	0.000125	CcSEcCtD
Methylprednisolone—Skin disorder—Doxorubicin—breast cancer	9.36e-06	0.000125	CcSEcCtD
Methylprednisolone—Paraesthesia—Epirubicin—breast cancer	9.36e-06	0.000125	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Doxorubicin—breast cancer	9.32e-06	0.000124	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP3A4—breast cancer	9.22e-06	0.00571	CrCbGaD
Methylprednisolone—Nausea—Docetaxel—breast cancer	9.18e-06	0.000122	CcSEcCtD
Methylprednisolone—Feeling abnormal—Methotrexate—breast cancer	9.17e-06	0.000122	CcSEcCtD
Methylprednisolone—Dyspepsia—Epirubicin—breast cancer	9.17e-06	0.000122	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Methotrexate—breast cancer	9.1e-06	0.000121	CcSEcCtD
Methylprednisolone—Dexamethasone—PTGS2—breast cancer	9.03e-06	0.00559	CrCbGaD
Methylprednisolone—Hypotension—Doxorubicin—breast cancer	9.01e-06	0.00012	CcSEcCtD
Methylprednisolone—Fatigue—Epirubicin—breast cancer	8.98e-06	0.00012	CcSEcCtD
Methylprednisolone—Nausea—Capecitabine—breast cancer	8.88e-06	0.000118	CcSEcCtD
Methylprednisolone—Urticaria—Methotrexate—breast cancer	8.84e-06	0.000118	CcSEcCtD
Methylprednisolone—Abdominal pain—Methotrexate—breast cancer	8.8e-06	0.000117	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—breast cancer	8.78e-06	0.000117	CcSEcCtD
Methylprednisolone—Insomnia—Doxorubicin—breast cancer	8.72e-06	0.000116	CcSEcCtD
Methylprednisolone—Paraesthesia—Doxorubicin—breast cancer	8.66e-06	0.000115	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—NDUFS3—breast cancer	8.62e-06	0.000344	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Epirubicin—breast cancer	8.59e-06	0.000114	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	8.57e-06	0.000342	CbGpPWpGaD
Methylprednisolone—Gastrointestinal pain—Epirubicin—breast cancer	8.52e-06	0.000114	CcSEcCtD
Methylprednisolone—Dyspepsia—Doxorubicin—breast cancer	8.49e-06	0.000113	CcSEcCtD
Methylprednisolone—Fatigue—Doxorubicin—breast cancer	8.31e-06	0.000111	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	8.3e-06	0.000331	CbGpPWpGaD
Methylprednisolone—Urticaria—Epirubicin—breast cancer	8.28e-06	0.00011	CcSEcCtD
Methylprednisolone—Abdominal pain—Epirubicin—breast cancer	8.24e-06	0.00011	CcSEcCtD
Methylprednisolone—Hypersensitivity—Methotrexate—breast cancer	8.2e-06	0.000109	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	8.2e-06	0.000327	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—COMT—breast cancer	8.19e-06	0.000326	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTP1—breast cancer	8.15e-06	0.000325	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	8.12e-06	0.000324	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CHST9—breast cancer	8.1e-06	0.000323	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—COMT—breast cancer	8.07e-06	0.000322	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	8.04e-06	0.00032	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NOTCH4—breast cancer	8e-06	0.000319	CbGpPWpGaD
Methylprednisolone—Asthenia—Methotrexate—breast cancer	7.99e-06	0.000106	CcSEcCtD
Methylprednisolone—Feeling abnormal—Doxorubicin—breast cancer	7.94e-06	0.000106	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—breast cancer	7.88e-06	0.000105	CcSEcCtD
Methylprednisolone—Pruritus—Methotrexate—breast cancer	7.88e-06	0.000105	CcSEcCtD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	7.85e-06	0.000313	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	7.73e-06	0.000308	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—COX11—breast cancer	7.68e-06	0.000306	CbGpPWpGaD
Methylprednisolone—Dexamethasone—ABCB1—breast cancer	7.68e-06	0.00475	CrCbGaD
Methylprednisolone—Hypersensitivity—Epirubicin—breast cancer	7.68e-06	0.000102	CcSEcCtD
Methylprednisolone—Urticaria—Doxorubicin—breast cancer	7.66e-06	0.000102	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—HSPA1B—breast cancer	7.63e-06	0.000304	CbGpPWpGaD
Methylprednisolone—Abdominal pain—Doxorubicin—breast cancer	7.62e-06	0.000102	CcSEcCtD
Methylprednisolone—Diarrhoea—Methotrexate—breast cancer	7.62e-06	0.000102	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	7.6e-06	0.000303	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	7.51e-06	0.0003	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTM1—breast cancer	7.49e-06	0.000299	CbGpPWpGaD
Methylprednisolone—Asthenia—Epirubicin—breast cancer	7.48e-06	9.96e-05	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	7.48e-06	0.000298	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—breast cancer	7.41e-06	0.000295	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	7.38e-06	0.000294	CbGpPWpGaD
Methylprednisolone—Pruritus—Epirubicin—breast cancer	7.37e-06	9.83e-05	CcSEcCtD
Methylprednisolone—Dizziness—Methotrexate—breast cancer	7.36e-06	9.81e-05	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCG2—breast cancer	7.32e-06	0.000292	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PGR—breast cancer	7.32e-06	0.000292	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—DNMT1—breast cancer	7.18e-06	0.000286	CbGpPWpGaD
Methylprednisolone—Diarrhoea—Epirubicin—breast cancer	7.13e-06	9.5e-05	CcSEcCtD
Methylprednisolone—Hypersensitivity—Doxorubicin—breast cancer	7.1e-06	9.47e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Biological oxidations—CYP1A1—breast cancer	7.1e-06	0.000283	CbGpPWpGaD
Methylprednisolone—Vomiting—Methotrexate—breast cancer	7.08e-06	9.44e-05	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—NCOA2—breast cancer	7.04e-06	0.000281	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SHMT1—breast cancer	7.02e-06	0.00028	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CDA—breast cancer	7.02e-06	0.00028	CbGpPWpGaD
Methylprednisolone—Rash—Methotrexate—breast cancer	7.02e-06	9.36e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Methotrexate—breast cancer	7.01e-06	9.35e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	7e-06	0.000279	CbGpPWpGaD
Methylprednisolone—Headache—Methotrexate—breast cancer	6.97e-06	9.3e-05	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—EZH2—breast cancer	6.95e-06	0.000277	CbGpPWpGaD
Methylprednisolone—Asthenia—Doxorubicin—breast cancer	6.92e-06	9.22e-05	CcSEcCtD
Methylprednisolone—Dizziness—Epirubicin—breast cancer	6.89e-06	9.18e-05	CcSEcCtD
Methylprednisolone—Pruritus—Doxorubicin—breast cancer	6.82e-06	9.09e-05	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—NOTCH3—breast cancer	6.8e-06	0.000271	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PARP1—breast cancer	6.8e-06	0.000271	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC2A5—breast cancer	6.76e-06	0.00027	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLCO1B1—breast cancer	6.76e-06	0.00027	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	6.67e-06	0.000266	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPS6—breast cancer	6.64e-06	0.000265	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	6.63e-06	0.000264	CbGpPWpGaD
Methylprednisolone—Vomiting—Epirubicin—breast cancer	6.62e-06	8.83e-05	CcSEcCtD
Methylprednisolone—Nausea—Methotrexate—breast cancer	6.61e-06	8.82e-05	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—breast cancer	6.6e-06	8.79e-05	CcSEcCtD
Methylprednisolone—Rash—Epirubicin—breast cancer	6.57e-06	8.76e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Epirubicin—breast cancer	6.56e-06	8.75e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	6.53e-06	0.000261	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APRT—breast cancer	6.53e-06	0.00026	CbGpPWpGaD
Methylprednisolone—Headache—Epirubicin—breast cancer	6.53e-06	8.7e-05	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	6.53e-06	0.00026	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	6.51e-06	0.00026	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ESR2—breast cancer	6.44e-06	0.000257	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	6.44e-06	0.000257	CbGpPWpGaD
Methylprednisolone—Dizziness—Doxorubicin—breast cancer	6.38e-06	8.5e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	6.3e-06	0.000251	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	6.28e-06	0.000251	CbGpPWpGaD
Methylprednisolone—Nausea—Epirubicin—breast cancer	6.19e-06	8.25e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—ESRRA—breast cancer	6.14e-06	0.000245	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ANGPTL4—breast cancer	6.14e-06	0.000245	CbGpPWpGaD
Methylprednisolone—Vomiting—Doxorubicin—breast cancer	6.13e-06	8.17e-05	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—NOTCH2—breast cancer	6.1e-06	0.000243	CbGpPWpGaD
Methylprednisolone—Rash—Doxorubicin—breast cancer	6.08e-06	8.1e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Doxorubicin—breast cancer	6.07e-06	8.09e-05	CcSEcCtD
Methylprednisolone—Headache—Doxorubicin—breast cancer	6.04e-06	8.05e-05	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	5.99e-06	0.000239	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	5.97e-06	0.000238	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NCOA1—breast cancer	5.94e-06	0.000237	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	5.85e-06	0.000233	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GPI—breast cancer	5.82e-06	0.000232	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HADHB—breast cancer	5.82e-06	0.000232	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	5.79e-06	0.000231	CbGpPWpGaD
Methylprednisolone—Nausea—Doxorubicin—breast cancer	5.73e-06	7.63e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—SYNJ2—breast cancer	5.71e-06	0.000228	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	5.69e-06	0.000227	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AR—breast cancer	5.69e-06	0.000227	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	5.68e-06	0.000226	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	5.64e-06	0.000225	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALDH1A1—breast cancer	5.55e-06	0.000221	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALDH7A1—breast cancer	5.55e-06	0.000221	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	5.51e-06	0.00022	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	5.49e-06	0.000219	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	5.37e-06	0.000214	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NME1—breast cancer	5.32e-06	0.000212	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—FHL2—breast cancer	5.32e-06	0.000212	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ADSL—breast cancer	5.32e-06	0.000212	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PHGDH—breast cancer	5.32e-06	0.000212	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—UMPS—breast cancer	5.32e-06	0.000212	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NDUFS3—breast cancer	5.31e-06	0.000212	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	5.29e-06	0.000211	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LDHB—breast cancer	5.22e-06	0.000208	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HPSE—breast cancer	5.22e-06	0.000208	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—BRIP1—breast cancer	5.22e-06	0.000208	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SIRT1—breast cancer	5.19e-06	0.000207	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	5.16e-06	0.000206	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SMAD4—breast cancer	5.12e-06	0.000204	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—VDR—breast cancer	5.11e-06	0.000204	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	5.1e-06	0.000203	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CHST9—breast cancer	4.99e-06	0.000199	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NCOR1—breast cancer	4.97e-06	0.000198	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	4.96e-06	0.000198	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMMR—breast cancer	4.95e-06	0.000197	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA3—breast cancer	4.95e-06	0.000197	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCC1—breast cancer	4.95e-06	0.000197	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—H2AFX—breast cancer	4.85e-06	0.000193	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARGC1B—breast cancer	4.79e-06	0.000191	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	4.76e-06	0.00019	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—COX11—breast cancer	4.73e-06	0.000189	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	4.69e-06	0.000187	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ERCC2—breast cancer	4.68e-06	0.000187	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	4.57e-06	0.000182	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	4.55e-06	0.000182	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA4—breast cancer	4.53e-06	0.00018	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CA9—breast cancer	4.53e-06	0.00018	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	4.47e-06	0.000178	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA2—breast cancer	4.41e-06	0.000176	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GPX2—breast cancer	4.41e-06	0.000176	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GPX4—breast cancer	4.36e-06	0.000174	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SULT1A1—breast cancer	4.36e-06	0.000174	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SHMT1—breast cancer	4.33e-06	0.000173	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CDA—breast cancer	4.33e-06	0.000173	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA1—breast cancer	4.26e-06	0.00017	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—IDH1—breast cancer	4.26e-06	0.00017	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	4.25e-06	0.00017	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—MYC—breast cancer	4.22e-06	0.000168	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	4.22e-06	0.000168	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NAT2—breast cancer	4.21e-06	0.000168	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLCO1B1—breast cancer	4.17e-06	0.000166	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC2A5—breast cancer	4.17e-06	0.000166	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APRT—breast cancer	4.02e-06	0.00016	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ESR1—breast cancer	3.91e-06	0.000156	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	3.88e-06	0.000155	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ESRRA—breast cancer	3.78e-06	0.000151	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ANGPTL4—breast cancer	3.78e-06	0.000151	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NOTCH1—breast cancer	3.78e-06	0.000151	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	3.75e-06	0.00015	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—DPYD—breast cancer	3.69e-06	0.000147	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MED12—breast cancer	3.69e-06	0.000147	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALDOA—breast cancer	3.63e-06	0.000145	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HADHB—breast cancer	3.59e-06	0.000143	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GPI—breast cancer	3.59e-06	0.000143	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOA3—breast cancer	3.53e-06	0.000141	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC2A2—breast cancer	3.5e-06	0.00014	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTR—breast cancer	3.43e-06	0.000137	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCG2—breast cancer	3.43e-06	0.000137	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CPT1A—breast cancer	3.43e-06	0.000137	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.42e-06	0.000136	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.42e-06	0.000136	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HPGDS—breast cancer	3.36e-06	0.000134	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HBA1—breast cancer	3.34e-06	0.000133	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ADSL—breast cancer	3.28e-06	0.000131	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PHGDH—breast cancer	3.28e-06	0.000131	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—FHL2—breast cancer	3.28e-06	0.000131	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NME1—breast cancer	3.28e-06	0.000131	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UMPS—breast cancer	3.28e-06	0.000131	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTT1—breast cancer	3.26e-06	0.00013	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ACHE—breast cancer	3.26e-06	0.00013	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—BRIP1—breast cancer	3.22e-06	0.000128	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HPSE—breast cancer	3.22e-06	0.000128	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LDHB—breast cancer	3.22e-06	0.000128	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SERPINE1—breast cancer	3.21e-06	0.000128	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	3.17e-06	0.000126	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP17A1—breast cancer	3.09e-06	0.000123	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ENO1—breast cancer	3.06e-06	0.000122	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS1—breast cancer	3.06e-06	0.000122	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA3—breast cancer	3.05e-06	0.000122	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMMR—breast cancer	3.05e-06	0.000122	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCC1—breast cancer	3.05e-06	0.000122	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2D6—breast cancer	3e-06	0.00012	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARGC1B—breast cancer	2.95e-06	0.000118	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOA2—breast cancer	2.94e-06	0.000117	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	2.86e-06	0.000114	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—FASN—breast cancer	2.85e-06	0.000114	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—BCHE—breast cancer	2.84e-06	0.000113	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC5A5—breast cancer	2.81e-06	0.000112	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA4—breast cancer	2.79e-06	0.000111	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CA9—breast cancer	2.79e-06	0.000111	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA2—breast cancer	2.72e-06	0.000108	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GPX2—breast cancer	2.72e-06	0.000108	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC2A1—breast cancer	2.71e-06	0.000108	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NQO1—breast cancer	2.71e-06	0.000108	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GPX4—breast cancer	2.68e-06	0.000107	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SULT1A1—breast cancer	2.68e-06	0.000107	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP3A4—breast cancer	2.64e-06	0.000105	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—IDH1—breast cancer	2.62e-06	0.000105	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA1—breast cancer	2.62e-06	0.000105	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP1B1—breast cancer	2.6e-06	0.000104	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NAT2—breast cancer	2.59e-06	0.000103	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	2.59e-06	0.000103	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSP90AA1—breast cancer	2.55e-06	0.000102	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOA1—breast cancer	2.48e-06	9.89e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—STK11—breast cancer	2.44e-06	9.75e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP19A1—breast cancer	2.44e-06	9.75e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MED12—breast cancer	2.27e-06	9.06e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—DPYD—breast cancer	2.27e-06	9.06e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—COMT—breast cancer	2.27e-06	9.06e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTP1—breast cancer	2.26e-06	9.02e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALDOA—breast cancer	2.24e-06	8.92e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMOX1—breast cancer	2.23e-06	8.89e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ITPR1—breast cancer	2.23e-06	8.87e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOA3—breast cancer	2.17e-06	8.66e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC2A2—breast cancer	2.16e-06	8.6e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTR—breast cancer	2.11e-06	8.43e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCG2—breast cancer	2.11e-06	8.43e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CPT1A—breast cancer	2.11e-06	8.43e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TYMS—breast cancer	2.1e-06	8.38e-05	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MAPK3—breast cancer	2.09e-06	8.33e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLA2G4A—breast cancer	2.08e-06	8.29e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTM1—breast cancer	2.08e-06	8.29e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOR1—breast cancer	2.08e-06	8.29e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HPGDS—breast cancer	2.07e-06	8.26e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HBA1—breast cancer	2.06e-06	8.21e-05	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MYC—breast cancer	2.03e-06	8.1e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ACHE—breast cancer	2.01e-06	8.01e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTT1—breast cancer	2.01e-06	8.01e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GPX1—breast cancer	1.99e-06	7.94e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP1A1—breast cancer	1.97e-06	7.86e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ERCC2—breast cancer	1.95e-06	7.79e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP17A1—breast cancer	1.9e-06	7.59e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ENO1—breast cancer	1.88e-06	7.51e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS1—breast cancer	1.88e-06	7.51e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2D6—breast cancer	1.85e-06	7.37e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTHFR—breast cancer	1.84e-06	7.32e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOA2—breast cancer	1.81e-06	7.23e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—FASN—breast cancer	1.76e-06	7.01e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—BCHE—breast cancer	1.75e-06	6.98e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC5A5—breast cancer	1.73e-06	6.9e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CAV1—breast cancer	1.69e-06	6.75e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NQO1—breast cancer	1.67e-06	6.66e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC2A1—breast cancer	1.67e-06	6.66e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP1B1—breast cancer	1.6e-06	6.39e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.57e-06	6.26e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CG—breast cancer	1.54e-06	6.15e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOA1—breast cancer	1.53e-06	6.09e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—STK11—breast cancer	1.51e-06	6e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP19A1—breast cancer	1.51e-06	6e-05	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AKT1—breast cancer	1.41e-06	5.62e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—COMT—breast cancer	1.4e-06	5.58e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTP1—breast cancer	1.39e-06	5.56e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMOX1—breast cancer	1.37e-06	5.48e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ITPR1—breast cancer	1.37e-06	5.47e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CD—breast cancer	1.36e-06	5.41e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—breast cancer	1.34e-06	5.34e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCB1—breast cancer	1.32e-06	5.26e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TYMS—breast cancer	1.3e-06	5.16e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NOS3—breast cancer	1.28e-06	5.11e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOR1—breast cancer	1.28e-06	5.11e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.28e-06	5.11e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTM1—breast cancer	1.28e-06	5.11e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GPX1—breast cancer	1.23e-06	4.89e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP1A1—breast cancer	1.21e-06	4.84e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ERCC2—breast cancer	1.2e-06	4.8e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CB—breast cancer	1.18e-06	4.71e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS2—breast cancer	1.17e-06	4.67e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTHFR—breast cancer	1.13e-06	4.51e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CAV1—breast cancer	1.04e-06	4.16e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTEN—breast cancer	1.02e-06	4.07e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CG—breast cancer	9.51e-07	3.79e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CD—breast cancer	8.36e-07	3.33e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—breast cancer	8.25e-07	3.29e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NOS3—breast cancer	7.89e-07	3.15e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CB—breast cancer	7.28e-07	2.9e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS2—breast cancer	7.22e-07	2.88e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CA—breast cancer	7.21e-07	2.87e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTEN—breast cancer	6.29e-07	2.51e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKT1—breast cancer	5.89e-07	2.35e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CA—breast cancer	4.44e-07	1.77e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKT1—breast cancer	3.63e-07	1.45e-05	CbGpPWpGaD
